Home/ Supplements/ Electrolytes/ Cell-U-Loss

Cell-U-Loss

product on market Tablet or Pill Herbalife Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 12% of ingredients have research evidence
B Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · methodology

This formula contains essential minerals and corn silk extract, which are commonly used to support fluid balance and electrolyte function. There is moderate evidence for the role of these minerals in cellular homeostasis, though clinical data for this specific combination is limited. The ingredient profile maintains a high safety rating.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for Cell-U-Loss
Open Full PDF View on NIH DSLD →
Details

Label Data

1 Tablet(s)
Serving Size
90
Servings
Botanical with Nutrients
Product Type
12%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

Calcium
25 mg (2% DV)
24 mg (6% DV)
Within RDA (0.1× RDA) 316 studies (A:8, B:159)
Sodium
22 mg (1% DV)
Potassium
33 mg (1% DV)
Corn Silk extract
134 mg
Parsley herb extract
10 mg
Market median: 300.0mg (159 products)
Asparagus root extract
5 mg

Other Ingredients

Maltodextrin Microcrystalline Cellulose Apple Cider Vinegar powder Croscarmellose Sodium Stearic Acid Silicon Dioxide Hydroxypropyl Methylcellulose Glycerine
Claims

Label Claims — Verification

Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

Recommended Use: Take 1 tablet 3 times per day with meals.

Formulation Notes

Strictly Kosher Rabbi S. D. Krausz Vaad Hakashrus D’Udvary

Cell-U-Loss is formulated with corn silk, an herb traditionally used to support healthy elimination of water.

Additional Information

Strictly Kosher Rabbi S. D. Krausz Vaad Hakashrus D’Udvary

30-day money-back guarantee. This exclusively formulated product is only available through Herbalife independent distributors.

Recycle this bottle

Made in USA with US and imported ingredients

L0111US-11 SKU0111

Metadata

Product Details

UPC / SKU0111US
DSLD Entry Date2019-05-28
Product TypeBotanical with Nutrients
FormTablet or Pill
DSLD ID201968
Data Updated2026-04-11
Research

Research Evidence

849
Research Sources
56
Avg Quality
450
Meta Analysis
152
Rct
137
Systematic Review
73
Clinical Trial
11
Regulatory Source
7
Other
7
Guideline
3
Openfda Safety
2
Cochrane Review
2
Observational
A Phosphate binders for preventing and treating chronic kidney disease-mineral and bone disorder (CKD-MBD)
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Calcium supplementation (other than for preventing or treating hypertension) for improving pregnancy and infant outcomes
Meta Analysis The Cochrane database of systematic reviews 2024 PubMed DOI
A Calcium supplementation (other than for preventing or treating hypertension) for improving pregnancy and infant outcomes
Meta Analysis The Cochrane database of systematic reviews 2015 PubMed DOI
A Vitamin and mineral supplementation for maintaining cognitive function in cognitively healthy people in mid and late life
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems
Meta Analysis The Cochrane database of systematic reviews 2025 PubMed DOI
A Dietary calcium supplementation for preventing colorectal cancer and adenomatous polyps
Systematic Review The Cochrane database of systematic reviews 2008 PubMed DOI
A Calcium and vitamin D for increasing bone mineral density in premenopausal women
Systematic Review The Cochrane database of systematic reviews 2023 PubMed DOI
A Dietary sodium, sodium-to-potassium ratio, and risk of stroke: A systematic review and nonlinear dose-response meta-analysis
Meta Analysis Clinical nutrition (Edinburgh, Scotland) 2019 PubMed DOI
A The association between circulating magnesium and clinically relevant outcomes in patients with chronic kidney disease: A systematic review and meta-analysis
Meta Analysis Clinical nutrition (Edinburgh, Scotland) 2021 PubMed DOI
A Calcium channel blockers versus other classes of drugs for hypertension
Systematic Review The Cochrane database of systematic reviews 2021 PubMed DOI
View all evidence for Electrolytes →
Compare

Similar Products

View all Electrolytes products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.